Catherine Schulte

Stock Analyst at Baird

(1.5)
# 1641
Out of 5,368 analysts
140
Total ratings
51.40%
Success rate
6.68%
Average return
18 Stocks
Name Action PT Current % Upside Ratings Updated
A Agilent Technologies
Maintains: Outperform
159 140
117.06 19.6% 16 May 22, 2025
MRVI Maravai LifeSciences
Maintains: Neutral
3 2
2.14 -6.54% 6 May 13, 2025
EXAS Exact Sciences
Maintains: Outperform
69 72
53.52 34.53% 14 May 2, 2025
AVTR Avantor
Maintains: Outperform
21 17
13.07 30.07% 11 Apr 28, 2025
TMO Thermo Fisher Scient...
Maintains: Outperform
603 573
402.51 42.36% 26 Apr 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
231 225
200.65 12.14% 9 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
1369 1034
1155.16 -10.49% 8 Apr 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
42 43
47.08 -8.67% 4 Apr 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
88 68
50.53 34.57% 9 Feb 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
182 165
n/a n/a 6 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
42 38
18.77 102.45% 7 Mar 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
56 33
33.55 -1.64% 3 Nov 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
4 2
n/a n/a 1 Jun 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
335 281
86.96 223.14% 6 Sep 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
21
n/a n/a 1 May 26, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
35 29
n/a n/a 5 Apr 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
208 217
342.12 -36.57% 7 Oct 30, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
17 20
165.33 -87.9% 1 Jun 28, 2018